ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
Dow Jones
38,675.68
1.18%
Brent Oil
83.135
0.01%
Bitcoin
64,105.20
0.17%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. MoonLake Immunotherapeutics (MLTX) Quote

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics (MLTX)

NASDAQ
45.26
2.69
(6.32%)
Closed May 06 4:00PM
Delayed by 15 minutes
45.26
0.00
(0.00%)
After Hours: 5:16PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
45.26
Bid
42.23
Ask
45.88
Volume
376,063
43.405 Day's Range 45.465
20.3501 52 Week Range 64.98
Market Cap
2.896B
Previous Close
42.57
Open
43.51
Last Trade
1
@
45.25
Last Trade Time
Financial Volume
$ 16,636,682
VWAP
44.2391
Average Volume (3m)
481,818
Shares Outstanding
63,886,757
Dividend Yield
-
PE Ratio
-65.70
Earnings Per Share (EPS)
-0.69
Revenue
-
Net Profit
-44.08M

About MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

Sector
Blank Checks
Industry
Pharmaceutical Preparations
Website
moonlaketx.com
Headquarters
Grand Cayman, Cym
Founded
2020
MoonLake Immunotherapeutics is listed in the Blank Checks sector of the NASDAQ with ticker MLTX. The last closing price for MoonLake Immunotherapeut... was $42.57. Over the last year, MoonLake Immunotherapeut... shares have traded in a share price range of $ 20.3501 to $ 64.98.

MoonLake Immunotherapeut... currently has 63,886,757 shares outstanding. The market capitalization of MoonLake Immunotherapeut... is $2.90 billion. MoonLake Immunotherapeut... has a price to earnings ratio (PE ratio) of -65.70.

MoonLake Immunotherapeut... (MLTX) Options Flow Summary

MLTX Options Flow

Overall Flow

Bullish

Net Premium

41k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

MLTX Latest News

More News

MoonLake Immunotherapeutics inks three-year technology partnership with Komodo Health to advance research on inflammatory skin and joint conditions 

MoonLake Immunotherapeutics inks three-year technology partnership with Komodo Health to advance research on inflammatory skin and joint conditions  MoonLake to tap into Komodo’s technology and...

April 10 2024
GlobeNewswire Inc.

Form 8-K - Current report

March 11 2024
Edgar (US Regulatory)

MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day

MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day Positive 24-week data...

March 10 2024
GlobeNewswire Inc.

MoonLake Immunotherapeutics to present MIRA trial data of Nanobody® sonelokimab in hidradenitis suppurativa as a late breaker at the AAD Annual Meeting 2024

MoonLake Immunotherapeutics to present MIRA trial data of Nanobody® sonelokimab in hidradenitis suppurativa as a late breaker at the AAD Annual Meeting 2024 ZUG, Switzerland, March 4, 2024 –...

March 04 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

February 29 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 29 2024
Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

February 29 2024
Edgar (US Regulatory)

Form 8-K - Current report

February 29 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
12.896.8208638187442.3745.46540.4528756842.20480934CS
4-0.76-1.6514558887446.0247.7240.4533681443.72344615CS
12-16.56-26.78744742861.8264.9840.4548181849.11336002CS
26-2.62-5.4720133667547.8864.9835.1156403149.0229314CS
5224.37116.65868836820.8964.9820.350159810948.59941346CS
15632.89265.88520614412.3764.984.2535650742.01237533CS
26032.89265.88520614412.3764.984.2535650742.01237533CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 6.8001
(254.17%)
31.01M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M
SHOTWSafety Shot Inc
$ 0.45
(45.16%)
644
AIPArteris Inc
$ 8.185
(38.03%)
1.11M
RGFReal Good Food Company Inc
$ 0.85
(37.32%)
4.26M
MNDRMobile health Network Solutions
$ 3.33
(-84.91%)
18.76M
NUVOHoldco Nuvo Group DG Ltd
$ 2.00
(-57.54%)
1.04M
SPTSprout Social Inc
$ 28.82
(-40.15%)
13.47M
UNITUniti Group Inc
$ 4.441
(-26.35%)
21.07M
IPDNProfessional Diversity Network Inc
$ 1.29
(-24.12%)
662.59k
AAPLApple Inc
$ 183.38
(5.98%)
163.22M
SQQQProShares UltraPro Short QQQ
$ 11.08
(-5.94%)
154.59M
JAGXJaguar Health Inc
$ 0.3164
(7.91%)
142.47M
NKLANikola Corporation
$ 0.6526
(6.55%)
106.88M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M

MLTX Discussion

View Posts
AKATITUS AKATITUS 9 months ago
Sleeping
Come on 70.00
👍️0
Monksdream Monksdream 10 months ago
MLTX new 52 week high
👍️0
AKATITUS AKATITUS 10 months ago
Haha. Now that's funny. 18,000 share buy at 52.00 dollars.
👍️0
AKATITUS AKATITUS 10 months ago
Damm some big buys at 54.00 WoW
👍️0
AKATITUS AKATITUS 10 months ago
Hope it busts soon.
👍️0
AKATITUS AKATITUS 10 months ago
Looks like a good churning. Will tomorrow be the same. ??????
👍️0
MiamiGent MiamiGent 10 months ago
MLTX Started the day with a bang. Falling back, presently

MOONLAKE IMMUNOTHERAPEUTICS
$41.80 +15.92 (+61.51%)
As of Jun-26-202310:46:16 AM ET

https://stockcharts.com/h-sc/ui?s=MLTX

Wolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday
BENZINGA
31 mins ago
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Monday. Here are some big stocks recording gains in today's session.

MoonLake Immunotherapeutics (NASDAQ:MLTX) jumped 75% to $45.50 after the company's Phase 2 study for Nanobody sonelokimabint met its primary endpoint in hidradenitis suppurativa.

(con't)
👍️0
AKATITUS AKATITUS 10 months ago
So pissed I was trying to sell somethings to buy 40ts them boom 100 bucks F##########
👍️0
Awl416 Awl416 10 months ago
Crazy
👍️0
crudeoil24 crudeoil24 2 years ago
MoonLake Immunotherapeutics (NASDAQ: MLTX) 10% owner Bihua Chen acquired a total of 5,635,000 shares at an average price of $10.00. To acquire these shares, it cost around $28.5 million.
👍️0

Your Recent History

NASDAQ
MLTX
MoonLake Immunotherapeut...
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved